MUDr. Lukáš Bajer, Ph.D.

Postdoctoral fellow

Publication

International Journal of Molecular Sciences. 2023; 24(11); 9386

A Current State of Proteomics in Adult and Pediatric Inflammatory Bowel Diseases: A Systematic Search and Review

Journal of Immunology Research. 2023; 2023(20 June 2023); 1535484

Serum TGF-β1 and CD14 Predicts Response to Anti-TNF-α Therapy in IBD

Frontiers in Cellular and Infection Microbiology. 2023; 13(January 10); 1064537

Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy

PLoS ONE. 2022; 17(12); e0277576

Association between ustekinumab therapy and changes in specific anti-microbial response; serum biomarkers; and microbiota composition in patients with IBD: A pilot study

World Journal of Gastroenterology. 2022; 28(36); 5300-5312

Histopathological assessment of the microscopic activity in inflammatory bowel diseases: What are we looking for?

Cells. 2021; 10(11); 3188

Fecal microbiome changes and specific anti-bacterial response in patients with ibd during anti-tnf therapy

Mucosal Immunology. 2021; 14(3); 691-702

Plectin ensures intestinal epithelial integrity and protects colon against colitis

Cells. 2019; 8(7); 719

Inflammatory Bowel Disease Types Differ in Markers of Inflammation; Gut Barrier and in Specific Anti-Bacterial Response